XML 14 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
At-the-Market Public Offering [Member]
Private Placement [Member]
Common Stock [Member]
Common Stock [Member]
At-the-Market Public Offering [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
At-the-Market Public Offering [Member]
Additional Paid in Capital [Member]
Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ 126,481     $ 20     $ 785,199     $ 15 $ (658,753)
Beginning balance, units at Dec. 31, 2023       20,386,606              
Issuance of common stock, net of issuance costs   $ 3,056 $ 89,454   $ 1 $ 17   $ 3,055 $ 89,437    
Issuance of common stock, net of issuance costs, units         350,664 16,973,103          
Issuance of pre-funded warrants in public offering/private placement 14,293           14,293        
Vesting of restricted stock, units       98,677              
Exercises of common stock options 151           151        
Exercises of common stock options, units       24,639              
Unrealized loss on available-for-sale securities (19)                 (19)  
Equity-based compensation expense 1,611           1,611        
Net loss (24,303)                   (24,303)
Ending balance at Mar. 31, 2024 210,724     $ 38     893,746     (4) (683,056)
Ending balance, units at Mar. 31, 2024       37,833,689              
Beginning balance at Dec. 31, 2023 126,481     $ 20     785,199     15 (658,753)
Beginning balance, units at Dec. 31, 2023       20,386,606              
Unrealized loss on available-for-sale securities (30)                    
Net loss (49,375)                    
Ending balance at Jun. 30, 2024 193,245     $ 39     901,349     (15) (708,128)
Ending balance, units at Jun. 30, 2024       38,551,059              
Beginning balance at Mar. 31, 2024 210,724     $ 38     893,746     (4) (683,056)
Beginning balance, units at Mar. 31, 2024       37,833,689              
Issuance of common stock, net of issuance costs   5,357     $ 1     5,356      
Issuance of common stock, net of issuance costs, units         526,953            
Vesting of restricted stock, units       131,859              
Exercises of common stock options 10           10        
Exercises of common stock options, units       1,703              
Issuance of common stock under employee stock purchase plan 145           145        
Issuance of common stock under employee stock purchase plan, units       56,855              
Unrealized loss on available-for-sale securities (11)                 (11)  
Equity-based compensation expense 2,092           2,092        
Net loss (25,072)                   (25,072)
Ending balance at Jun. 30, 2024 193,245     $ 39     901,349     (15) (708,128)
Ending balance, units at Jun. 30, 2024       38,551,059              
Beginning balance at Dec. 31, 2024 137,246     $ 40     920,609     47 (783,450)
Beginning balance, units at Dec. 31, 2024       40,468,141              
Issuance of common stock, net of issuance costs 135,367 $ 246   $ 36     135,331 $ 246      
Issuance of common stock, net of issuance costs, units       35,739,810 61,542            
Issuance of pre-funded warrants in public offering/private placement 52,590           52,590        
Issuance of common stock in private placement for payment of developmental milestone consideration 5,000     $ 1     4,999        
Issuance of common stock in private placement for payment of developmental milestone consideration, units       975,496              
Vesting of restricted stock, units       247,970              
Unrealized loss on available-for-sale securities (45)                 (45)  
Equity-based compensation expense 3,341           3,341        
Net loss (39,282)                   (39,282)
Ending balance at Mar. 31, 2025 294,463     $ 77     1,117,116     2 (822,732)
Ending balance, units at Mar. 31, 2025       77,492,959              
Beginning balance at Dec. 31, 2024 $ 137,246     $ 40     920,609     47 (783,450)
Beginning balance, units at Dec. 31, 2024       40,468,141              
Exercises of common stock options, units 2,733                    
Unrealized loss on available-for-sale securities $ (85)                    
Net loss (78,762)                    
Ending balance at Jun. 30, 2025 258,291     $ 78     1,120,463     (38) (862,212)
Ending balance, units at Jun. 30, 2025       77,602,741              
Beginning balance at Mar. 31, 2025 294,463     $ 77     1,117,116     2 (822,732)
Beginning balance, units at Mar. 31, 2025       77,492,959              
Vesting of restricted stock, units       32,189              
Exercises of common stock options 6           6        
Exercises of common stock options, units       2,733              
Issuance of common stock under employee stock purchase plan 197     $ 1     196        
Issuance of common stock under employee stock purchase plan, units       74,860              
Unrealized loss on available-for-sale securities (40)                 (40)  
Equity-based compensation expense 3,145           3,145        
Net loss (39,480)                   (39,480)
Ending balance at Jun. 30, 2025 $ 258,291     $ 78     $ 1,120,463     $ (38) $ (862,212)
Ending balance, units at Jun. 30, 2025       77,602,741